François Gaudet

5.4k total citations · 3 hit papers
23 papers, 4.1k citations indexed

About

François Gaudet is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, François Gaudet has authored 23 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Oncology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in François Gaudet's work include CAR-T cell therapy research (9 papers), Epigenetics and DNA Methylation (9 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). François Gaudet is often cited by papers focused on CAR-T cell therapy research (9 papers), Epigenetics and DNA Methylation (9 papers) and Monoclonal and Polyclonal Antibodies Research (7 papers). François Gaudet collaborates with scholars based in United States, Germany and Singapore. François Gaudet's co-authors include Rudolf Jaenisch, Amir Eden, Alpana Waghmare, Heinrich Leonhardt, Jessica Dausman, Joe W. Gray, Laurie Jackson‐Grusby, John Hodgson, Julia K. Kurash and Hong Lei and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

François Gaudet

23 papers receiving 4.0k citations

Hit Papers

Induction of Tumors in Mice by Genomic Hypomethylation 2003 2026 2010 2018 2003 2003 2008 250 500 750 1000

Peers

François Gaudet
Chih-Lin Hsieh United States
Jutta Kirfel Germany
Susan K. Logan United States
M.G. Byers United States
François Gaudet
Citations per year, relative to François Gaudet François Gaudet (= 1×) peers Genta Nagae

Countries citing papers authored by François Gaudet

Since Specialization
Citations

This map shows the geographic impact of François Gaudet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Gaudet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Gaudet more than expected).

Fields of papers citing papers by François Gaudet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Gaudet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Gaudet. The network helps show where François Gaudet may publish in the future.

Co-authorship network of co-authors of François Gaudet

This figure shows the co-authorship network connecting the top 25 collaborators of François Gaudet. A scholar is included among the top collaborators of François Gaudet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Gaudet. François Gaudet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frerichs, Kristine A., Marloes E.C. Broekmans, Berris van Kessel, et al.. (2020). Preclinical Activity of JNJ-7957, a Novel BCMA×CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab. Clinical Cancer Research. 26(9). 2203–2215. 68 indexed citations
2.
Rudnick, Stephen I., Leopoldo Luistro, Melissa Smith, et al.. (2020). Blockade of VLA4 sensitizes leukemic and myeloma tumor cells to CD3 redirection in the bone marrow microenvironment. Blood Cancer Journal. 10(6). 65–65. 23 indexed citations
3.
Pillarisetti, Kodandaram, Gordon Powers, Leopoldo Luistro, et al.. (2020). Teclistamab is an active T cell–redirecting bispecific antibody against B-cell maturation antigen for multiple myeloma. Blood Advances. 4(18). 4538–4549. 90 indexed citations
4.
Diem, Michael, Weirong Wang, Robert Schulingkamp, et al.. (2020). Abstract 5662: JNJ-67571244: A novel anti-CD33 C2 domain binding bispecific antibody with potent T cell redirection activity. Cancer Research. 80(16_Supplement). 5662–5662. 1 indexed citations
5.
Diem, Michael, Weirong Wang, Robert Schulingkamp, et al.. (2020). A novel C2 domain binding CD33xCD3 bispecific antibody with potent T-cell redirection activity against acute myeloid leukemia. Blood Advances. 4(5). 906–919. 35 indexed citations
6.
Kaur, Mandeep, Adam Drake, Guangan Hu, et al.. (2019). Induction and Therapeutic Targeting of Human NPM1c+ Myeloid Leukemia in the Presence of Autologous Immune System in Mice. The Journal of Immunology. 202(6). 1885–1894. 11 indexed citations
7.
Rudnick, Stephen I., Leopoldo Luistro, Diana Chin, et al.. (2016). The Impact of the Bone Marrow Microenvironment on T Cell Redirection Therapeutics. Blood. 128(22). 2752–2752. 1 indexed citations
8.
Pillarisetti, Kodandaram, Eric T. Baldwin, Alexander Babich, et al.. (2016). Development of a New BCMAxCD3 Duobody® Antibody for Multiple Myeloma. Blood. 128(22). 2116–2116. 8 indexed citations
9.
Babich, Alexander, Yingzhe Li, François Gaudet, et al.. (2016). Immunoprofiling of Normal Human Donor Blood Identified Potential Pharmacodynamic Markers for JNJ-63709178 (CD123xCD3) Duobody® Antibody Treatment. Blood. 128(22). 5215–5215. 1 indexed citations
10.
Forslund, Ann, Khaja Syed, Amy Axel, et al.. (2016). Ex Vivo Activity Profile of the CD123xCD3 Duobody® Antibody JNJ-63709178 Against Primary Acute Myeloid Leukemia Bone Marrow Samples. Blood. 128(22). 2875–2875. 3 indexed citations
11.
Kurash, Julia K., Hong Lei, Qiong Shen, et al.. (2008). Methylation of p53 by Set7/9 Mediates p53 Acetylation and Activity In Vivo. Molecular Cell. 29(3). 392–400. 178 indexed citations
12.
Wang, Jing, Sarah Hevi, Julia K. Kurash, et al.. (2008). The lysine demethylase LSD1 (KDM1) is required for maintenance of global DNA methylation. Nature Genetics. 41(1). 125–129. 626 indexed citations breakdown →
13.
Howard, Georgette, Rachel Eiges, François Gaudet, Rudolf Jaenisch, & Amir Eden. (2007). Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice. Oncogene. 27(3). 404–408. 241 indexed citations
14.
Gaudet, François, William M. Rideout, Alex Meissner, et al.. (2004). Dnmt1 Expression in Pre- and Postimplantation Embryogenesis and the Maintenance of IAP Silencing. Molecular and Cellular Biology. 24(4). 1640–1648. 89 indexed citations
15.
Gaudet, François, John Hodgson, Amir Eden, et al.. (2003). Induction of Tumors in Mice by Genomic Hypomethylation. Science. 300(5618). 489–492. 1150 indexed citations breakdown →
16.
Eden, Amir, François Gaudet, Alpana Waghmare, & Rudolf Jaenisch. (2003). Chromosomal Instability and Tumors Promoted by DNA Hypomethylation. Science. 300(5618). 455–455. 1013 indexed citations breakdown →
17.
Gauthier, Benoit R., Malcolm Robb, François Gaudet, Geoffrey S. Ginsburg, & Ruth McPherson. (1999). Characterization of a cholesterol response element (CRE) in the promoter of the cholesteryl ester transfer protein gene: functional role of the transcription factors SREBP-1a, -2, and YY1.. Journal of Lipid Research. 40(7). 1284–1293. 44 indexed citations
18.
Lee‐Kirsch, Min Ae, François Gaudet, M. Cristina Cardoso, & Klaus Lindpaintner. (1999). Distinct Renin Isoforms Generated by Tissue-Specific Transcription Initiation and Alternative Splicing. Circulation Research. 84(2). 240–246. 106 indexed citations
19.
Gaudet, François, Dale Talbot, Heinrich Leonhardt, & Rudolf Jaenisch. (1998). A Short DNA Methyltransferase Isoform Restores Methylation In Vivo. Journal of Biological Chemistry. 273(49). 32725–32729. 46 indexed citations
20.
Gaudet, François & Geoffrey S. Ginsburg. (1995). Transcriptional Regulation of the Cholesteryl Ester Transfer Protein Gene by the Orphan Nuclear Hormone Receptor Apolipoprotein AI Regulatory Protein-1. Journal of Biological Chemistry. 270(50). 29916–29922. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026